← back to search

António Lobo

X-Fab (Germany) · DE
Area of research
Psychiatry and Mental health · Social Psychology
Research interest
Research interests include Schizophrenia research and treatment, Dementia and Cognitive Impairment Research, Mental Health Treatment and Access, and Mental Health and Psychiatry.
h-index
70
citations
20,772
works
527
NIH funding
primary concept
email

Recent publications

Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach.
2025cited by 2position: contributordoi
Lifestyle and incident dementia: A COSMIC individual participant data meta‐analysis
Alzheimer s & Dementia 2024cited by 25position: middledoi
Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic
The Lancet Regional Health - Western Pacific 2024cited by 20position: middledoi
The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysis
European Psychiatry 2024cited by 5position: contributordoi
From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First‐Episode Psychosis
Acta Psychiatrica Scandinavica 2024cited by 3position: contributordoi
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study.
2024cited by 1position: contributordoi
Sex differences in dementia risk and risk factors: Individual‐participant data analysis using 21 cohorts across six continents from the COSMIC consortium
Alzheimer s & Dementia 2023cited by 121position: middledoi
Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late Life
JAMA Network Open 2023cited by 92position: middledoi
Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10-year follow-up community study.
2023cited by 11position: contributordoi
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort
Psychiatry Research 2023cited by 4position: contributordoi
Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls.
2023cited by 0position: contributordoi
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis.
2022cited by 7position: contributordoi
Cortical thinning over two years after first-episode psychosis depends on age of onset.
2022cited by 4position: contributordoi
The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study
Psychiatry Research 2022cited by 3position: contributordoi
Depression in internal medicine inpatients at the time of hospital discharge and referral to primary care
The European Journal of Psychiatry 2022cited by 0position: contributordoi
Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality
JAMA Internal Medicine 2021cited by 108position: middledoi
COVID-19 and dementia: experience from six European countries.
2021cited by 16position: contributordoi
The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis
Journal of Clinical Medicine 2021cited by 15position: contributordoi
Differences in Trajectories and Predictive Factors of Cognition over Time in a Sample of Cognitively Healthy Adults, in Zaragoza, Spain.
2021cited by 10position: contributordoi
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood.
2021cited by 9position: contributordoi
Can Physical Activity Reduce the Risk of Cognitive Decline in Apolipoprotein e4 Carriers? A Systematic Review.
2021cited by 7position: contributordoi
Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study
Alzheimer s Research & Therapy 2020cited by 165position: middledoi
Does parity matter in women’s risk of dementia? A COSMIC collaboration cohort study
BMC Medicine 2020cited by 78position: middledoi
Parity and the risk of incident dementia: a COSMIC study
Epidemiology and Psychiatric Sciences 2020cited by 49position: middledoi
Pathways to care for people with dementia: An international multicentre study.
2020cited by 22position: contributordoi
Association between Anxiety and Vascular Dementia Risk: New Evidence and an Updated Meta-Analysis.
2020cited by 11position: contributordoi
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period.
2020cited by 11position: contributordoi
Education and the moderating roles of age, sex, ethnicity and apolipoprotein epsilon 4 on the risk of cognitive impairment.
2020cited by 10position: contributordoi
The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory
Psychological Medicine 2020cited by 8position: contributordoi
Anxiety and Risk of Vascular Dementia in an Elderly Community Sample: The Role of Sex.
2020cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 24 papers (2019–2025)Miquel Bernardo · Centro Universitário São Camilo13 papers (2019–2025)Manuel J. Cuesta · Gobierno de Navarra12 papers (2019–2025)Silvia Amoretti · Fundació Clínic per a la Recerca Biomèdica8 papers (2020–2024)Elena De La Serna · Centro de Investigación Biomédica en Red8 papers (2019–2024)Eduard Vieta · Mid Sweden University8 papers (2020–2025)Miquel Bioque · Associació de la Paràlisi Cerebral7 papers (2019–2023) · 7 papers (2020–2024)Ana M González‐Pinto · Complejo Hospitalario Universitario de Santiago6 papers (2019–2024)Salvador Sarró · GGZ inGeest6 papers (2019–2023)Mara Parellada · Instituto de Salud Carlos III6 papers (2020–2022)Edith Pomarol-Clotet · Schizophrenia Research Institute5 papers (2021–2024)Covadonga M. Díaz-Caneja · Hospital General Universitario Gregorio Marañón4 papers (2022–2024)Patricia Gracia-García · Universidad de Zaragoza4 papers (2020–2023)Ana M. Sánchez-Torres · Navarrabiomed4 papers (2020–2025)Sergi Mas · Karolinska Institutet4 papers (2021–2025)María Florencia Forte · Biomedical Research Institute3 papers (2024–2025)Patricia Gasso · Health Net3 papers (2020–2024)Derek Clougher · Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer3 papers (2024–2024)Anabel Martinez-Aran · Barcelona Institute for Science and Technology3 papers (2022–2024)